Latest Cardiovascular Disease (CVD) News
Plasma TMAO levels among patients predict both near- and long-term risks of incident cardiovascular events.
Participants with high TG and low HDL levels had a 1.32-fold greater HR for CHD than those with normal TG and normal HDL levels.
In a large study, testosterone replacement therapy was associated with a 33% lower risk of cardiac and stroke events among hypogonadal men.
The presence of CAC among individuals aged between 32 and 46 years was associated with increased risk of fatal and nonfatal CHD during 12.5 years of follow-up.
Those without traditional cardiovascular risk factors are disproportionately prone to these cardiac diseases in the setting of alcohol abuse.
Adjusted rates of hospitalization for AF increased by almost 1% per year between 1999 and 2013.
Irregular eating patterns appear less favorable for achieving a healthy cardiometabolic profile.
Baseline LDL-C was lower in patients with LDL-C <25 versus ≥25 mg/dl.
Patients with an eGFR below 60 mL/min/1.73 m2 were more likely to die in the hospital or be discharged to hospice.
Higher RHR was significantly associated with all-cause mortality and cardiovascular events in older but not younger participants.
The potential safety signals of myopathies and liver injury raise the hypothesis that the safety profile of RYR is similar to that of statins.
Dialysis facilities with the least control of PTH, Ca, and P had the greatest risks.
Sitagliptin did not significantly impact the primary composite, death, heart failure hospitalization, severe hypoglycemia, rates of acute pancreatitis and pancreatic cancer, or serious adverse events.
New guidelines suggest aiming for a systolic pressure less than 150 mm Hg in hypertensive individuals aged 60 or older.
The continued observation of heterogeneity of treatment response by baseline lipids suggests that fenofibrate therapy may reduce CVD in patients with diabetes.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)